Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 5:07 pm Sale |
2023-12-31 | 13G | Nanobiotix S.A. NBTX |
Artal Participations S.a r.l | 0 0.000% |
-3,069,034 (Position Closed) |
Filing History |
| 2024-02-09 5:06 pm Sale |
2023-12-31 | 13G | Morphic Holding, Inc. MORF |
Artal Participations S.a r.l | 2,138,188 4.300% |
-11,812 (-0.55%) |
Filing History |
| 2024-02-09 5:06 pm Sale |
2023-12-31 | 13G | Cyclerion Therapeutics, Inc. CYCN |
Artal Participations S.a r.l | 138,955 5.700% |
-1 (-0.00%) |
Filing History |
| 2024-02-09 5:05 pm Purchase |
2023-12-31 | 13G | Silence Therapeutics plc SLN |
Artal Participations S.a r.l | 9,000,000 7.800% |
1,500,000 (+20.00%) |
Filing History |
| 2024-02-09 5:04 pm Purchase |
2023-12-31 | 13G | CAVA Group, Inc. CAVA |
Artal Participations S.a r.l | 32,007,990 28.200% |
32,007,990 (New Position) |
Filing History |
| 2024-02-09 5:03 pm Purchase |
2023-12-31 | 13G | GlycoMimetics, Inc. GLYC |
Artal Participations S.a r.l | 8,589,064 13.300% |
2,015,266 (+30.66%) |
Filing History |
| 2024-01-22 4:31 pm Purchase |
2024-01-11 | 13G | Solid Biosciences Inc. SLDB |
Artal Participations S.a r.l | 2,717,538 7.300% |
2,717,538 (New Position) |
Filing History |
| 2024-01-11 4:30 pm Purchase |
2023-12-14 | 13G | Gossamer Bio, Inc. GOSS |
Artal Participations S.a r.l | 13,108,880 5.800% |
13,108,880 (New Position) |
Filing History |
| 2023-11-13 4:30 pm Purchase |
2023-11-03 | 13G | Korro Bio, Inc. KRRO |
Artal Participations S.a r.l | 418,605 5.200% |
418,605 (New Position) |
Filing History |
| 2023-09-01 4:12 pm Purchase |
2023-08-24 | 13G | Silence Therapeutics plc SLN |
Artal Participations S.a r.l | 7,500,000 6.800% |
7,500,000 (New Position) |
Filing History |
| 2023-06-12 4:30 pm Purchase |
2023-06-01 | 13G | Cartesian Therapeutics, Inc. RNAC |
Artal Participations S.a r.l | 340,233 6.600% |
340,233 (New Position) |
Filing History |
| 2023-03-31 4:15 pm Purchase |
2023-03-23 | 13G | Harpoon Therapeutics, Inc. HARP |
Artal Participations S.a r.l | 234,744 6.100% |
234,744 (New Position) |
Filing History |
| 2023-02-13 5:18 pm Purchase |
2023-02-09 | 13G | GlycoMimetics, Inc. GLYC |
Artal Participations S.a r.l | 6,573,798 12.500% |
6,573,798 (New Position) |
Filing History |
| 2023-02-10 7:56 pm Purchase |
2022-09-28 | 13G | Morphic Holding, Inc. MORF |
Artal Participations S.a r.l | 2,150,000 5.600% |
564,951 (+35.64%) |
Filing History |
| 2023-02-10 7:53 pm Purchase |
2022-12-31 | 13G | SQZ Biotechnologies Company SQZB |
Artal Participations S.a r.l | 160,631 5.500% |
160,631 (New Position) |
Filing History |
| 2023-02-10 7:41 pm Purchase |
2022-12-31 | 13G | Syros Pharmaceuticals, Inc. SYRS |
Artal Participations S.a r.l | 1,463,829 7.200% |
1,113,829 (+318.24%) |
Filing History |
| 2023-02-10 7:36 pm Sale |
2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
Artal Participations S.a r.l | 2,243,352 6.300% |
-42,222 (-1.85%) |
Filing History |
| 2023-02-10 7:34 pm Sale |
2022-12-31 | 13G | Omega Alpha SPAC OMEG |
Artal Participations S.a r.l | 0 0.000% |
-750,000 (Position Closed) |
Filing History |
| 2023-02-10 7:33 pm Purchase |
2022-12-31 | 13G | Scholar Rock Holding Corporation SRRK |
Artal Participations S.a r.l | 10,555,278 19.800% |
230,236 (+2.23%) |
Filing History |
| 2023-02-10 7:31 pm Unchanged |
2022-12-31 | 13G | NexImmune, Inc. NEXI |
Artal Participations S.a r.l | 48,000 4.600% |
0 (Unchanged) |
Filing History |